Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Astria Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 102 | 100 | −2 |
| Shares | 57.6M | 55.6M | −2.06M (−3.6%) |
| Value | $810.6M | $505.8M | −$304.8M (−37.6%) |
New holders (23)
Institutions that held Astria Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (25)
Institutions that held Astria Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.